digipharm®
Home •  Site Map  •  Research  •  Reports  •  International Experts  •  Music Preparations  •  Fundamentals  •  News  •  Questions  •  Shop
digipharm®

SCIENTIFIC RESEARCH
REPORTS

The American Institute
of Stress

World Health
Organization (WHO)

Republic of Belarus

Stress + Heart Disease

The Unborn Child

Special Care Baby Unit

Harmonic Therapy

The Benefits of
Harmonic Information

Social Medical Significance

Headaches & Migraine

Harmonic Information
as a Modern Medication

Intensive Care Unit

MRT Music / Function

Chernobyl

 

 






Peter Hübner - Micro Music Laboratories
Peter Hübner - Micro Music Laboratories
Page   1 2
The Benefits of Harmonic Information in Digital Pharmaceutics
We have also suc­cess­fully used this method in ob­stet­rics, par­ticu­larly where there have been com­pli­ca­tions with the preg­nancy, such as a risk of los­ing the preg­nancy and of toxe­mia.

The group at risk of los­ing the preg­nancy com­prised 15 women in the 10th to 13th week of preg­nancy. The risk of ter­mi­na­tion stemmed from neuro-psy­cho­logi­cal fac­tors and from se­vere stress. The com­plex labo­ra­tory ex­ami­na­tions car­ried out on the preg­nant women on the first day also in­cluded an ex­ami­na­tion of the lev­els of the hor­mones cor­ti­sol, pro­ges­ter­one and es­tra­diol. In ad­di­tion, vaginal smears were ex­am­ined in or­der to de­ter­mine the hor­mo­nal saturation. As­sess­ment of the emo­tional-per­sonal sphere was again car­ried out with the help of the MMPI. The con­trol group also com­prised 15 women.

They re­ceived con­ven­tional ther­apy to pre­vent loss of preg­nancy, and this in­cluded seda­tive and spasmolytic remedies and vita­mins.

The pa­tients in the MRT-Mu­sic® group lis­tened to the mu­sic 1–2 times a day for 30-60 min­utes, a to­tal of 8–12 times. The blood sam­ples were taken in the morn­ings be­fore treat­ment and again af­ter treat­ment. Eve­ry three days smears were ex­am­ined in the clini­cal labo­ra­tory.

When the pa­tients were ad­mit­ted to the hos­pi­tal, the karyopyknosic in­dex (KPI) in the smears fluctuated be­tween 16% and 21%. As a re­sult of the treat­ment, the KPI in the MRT-Mu­sic® group fell af­ter only 3 days to 10%–12% and in the con­trol group only down to 14%–17%. Af­ter 6 days, it was down to 7%–8% and 11%–13% re­spec­tively.

Prior to treatment:

Cortisol 765 nmol / l,
progesterone 11.4 nmol / l, estradiol 1.66 nmol / l

After treatment:

Cortisol 485 nmol / l,
progesterone 22.8 nmol / l, estradiol 0.92 nmol / l


Prior to treatment:

Cortisol 720 nmol / l,
progesterone 14.2 nmol / l, estradiol 1.8 nmol / l

After treatment:

Cortisol 590 nmol / l,
progesterone 18.1 nmol / l, estradiol 1.8 nmol / l



As this shows, the level of cor­ti­sol and es­tra­diol for the preg­nant women in the MRT-Mu­sic group went down by 40 – 50% (in the con­trol group by 27%), and the pro­ges­ter­one level dou­bled.

Af­ter the MRT-Mu­sic® treat­ment, the men­tal state of 69.2% of the preg­nant women had nor­mal­ized and there was no in­ci­dence of a de­te­rio­ra­tion, whilst in the con­trol group – treated in the con­ven­tional way – an im­prove­ment in the men­tal state was only evi­dent in 40% of the women.

Ap­proxi­mately the same per­cent­age was char­ac­ter­ized by a de­te­rio­ra­tion in the extant health dis­or­ders. Fur­ther­more, there was an im­prove­ment in the gen­eral health and mood of the women in the MRT-Mu­sic® group. Sleep, high blood pres­sure, and ap­pe­tite be­came nor­mal.

The women in the MRT-Mu­sic® group re­quired 9–11 days hos­pi­tal treat­ment, whilst the con­trol group had to be treated for 14– 16 days.

We also gath­ered in­ter­est­ing data when us­ing Medi­cal Reso­nance Ther­apy Mu­sic® to treat blood pres­sure, and ap­pe­tite be­came nor­mal.

The women in the MRT-Mu­sic® group re­quired 9–11 days hos­pi­tal treat­ment, whilst the con­trol group had to be treated for 14– 16 days.

We also gath­ered in­ter­est­ing data when us­ing Medi­cal Reso­nance Ther­apy Mu­sic® to treat blood pres­sure, gen­eral state, sleep, changes in the car­dioto­cographic status of the foe­tus.

The pa­tients in the con­trol group were not treated with Medi­cal Reso­nance Ther­apy Mu­sic, but in­stead were treated in the usual con­ven­tional way (spasmolytics, seda­tives, and hy­poten­sives).

As the data re­corded in­di­cate, af­ter only 6 ses­sions with Medi­cal Reso­nance Ther­apy Mu­sic®, the vari­abil­ity and the num­ber of ac­cel­era­tions in­creased, which shows the im­prove­ment in the status of the foe­tus. Nor­mali­za­tion of the blood pres­sure, the gen­eral con­di­tion and sleep oc­curred in 82% of the women.

Con­se­quently, this mu­sic can be suc­cess­fully used in the treat­ment of toxe­mia.

A new com­po­nent in our re­search work is the study of the ef­fects of Medi­cal Reso­nance Ther­apy Mu­sic® on the im­mune sys­tem of preg­nant women.
Ten women di­ag­nosed with a threat of mis­car­riage took part in the study.
They lis­tened to the mu­sic for a week.

Af­ter the treat­ment, be­sides an im­prove­ment in the gen­eral con­di­tion, posi­tive changes were reg­is­tered in a se­ries of im­mu­nologi­cal pa­rame­ters, in­clud­ing an in­crease in the T-lymphocyte level, Nor­mali­za­tion of their func­tional ac­tiv­ity, the re­la­tion­ship of the T-helper, T-sup­pressors, the pro­duc­tion of immunoglobulins (in­clud­ing a re­duc­tion in immunoglobulin M).

The con­se­quence of all this is a clear re­duc­tion of the circulating immuno-com­plexes in the blood serum. No stimu­la­tion of the im­mune sys­tem’s phagocytic link has been as­cer­tained. This re­search is still con­tinu­ing and should be con­cluded in the next 2 –3 months.

Medi­cal Reso­nance Ther­apy Mu­sic® is not only used for in-pa­tient treat­ment. In our women’s ad­vice cen­ter, we have a psy­cho­logi­cal re­laxa­tion fa­cil­ity where the main method of treat­ment is Medi­cal Reso­nance Ther­apy Mu­sic®.

Women who be­long to the fol­low­ing risk groups are treated:

toxemia

premature birth

extragenital pathology

hypertonia

vegetative
angiodystonia

neurasthenia

And as I have already said,
we also use this method when
preparing patients for surgery.

Prof. Dr. med. G. Gerassimowitsch



Out-pa­tient treat­ment in­volves 12–18 ses­sions, where­by the mu­sic must be lis­tened to eve­ry day. Gen­er­ally, a re­duc­tion in risk is seen in the women. So last year, as a re­sult of this ther­apy, we had no se­ri­ous cases of toxe­mia, no com­pli­ca­tions dur­ing the post-op­era­tive pe­riod and a re­duc­tion in the num­ber of pre­ma­ture births.

I would like to thank the com­poser Peter Hübner and all his col­leagues for de­vel­op­ing an ob­jec­tive and ob­vi­ously ef­fec­tive means of pro­phy­laxis and method of treat­ment for vari­ous com­pli­ca­tions and ill­nesses with the help of Medi­cal Reso­nance Ther­apy Mu­sic®. This method can be used suc­cess­fully in ob­stet­rics and Gy­nae­col­ogy This is a rec­og­nized method in Bela­rus. It needs fur­ther sci­en­tific re­search and should be used more ex­ten­sively in prac­tice.

The method is not only suit­able for the pur­poses men­tioned above, but also for screen­ing all preg­nant women and those suf­fer­ing from gy­ne­co­logi­cal com­plaints who re­quire sur­gi­cal treat­ment. For Bela­rus, this method gains par­ticu­lar sig­nifi­cance in con­nec­tion with the Cher­nobyl ca­tas­tro­phe, where the most im­por­tant health dis­or­der is chronic stress. I would like to give ex­pres­sion to the hope that our col­labo­ra­tion in the fu­ture sci­en­tific ex­plo­ra­tion of this method as a pro­phy­lac­tic and broad spec­trum treat­ment for the main­te­nance and strength­en­ing of the reprod­uctive health of women will de­velop suc­cess­fully and fruit­fully.



<<
MEDICAL RESONANCE THERAPY MUSIC®
Medical Music Preparations on CD
RRR 934 Pregnancy & Birth
Pregnancy and Birth


 

If you like to look at the complete program,
if you like to listen to the Medical Music Preparation or
if you want to download it,
please click on the CD-cover above.

If you click on the title, it will lead you to the
scientific research.

With kind permission of AAR EDITION INTERNATIONAL
© 1998-  DIGIPHARM >